Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evolus Inc.

Division of Alphaeon Corp.
www.evolus.com

Latest From Evolus Inc.

Keeping Track: CDER Approves Its First Two Novel Agents Of 2019

The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA Performance Tracker Drug Review

With Jeuveau Approval, Evolus Will Focus On The Beauty Business To Gain Market Share

Evolus believes its focus on the beauty business will be a differentiator for its neurotoxin Jeuveau. The company will publish head-to-head results against Botox alongside the Spring 2019 launch and does not expect a new trade secrets complaint from Botox maker Allergan to delay its product.

Approvals Launches

2018 Complete Response Letters: Efficacy Issues Drove Most Product Rejections

US FDA issued at least seven rejections to novel products; opioid analgesic sponsors had very little success, while biosimilar developers had a so-so year.

Complete Response Letters Drug Review

Korean Pharma Finds Own Way To Collaborative And Open Innovation

Taking into consideration global and domestic trends, South Korean pharmas are increasingly finding their own strategies to seek open innovation and collaborations to develop novel new drugs. Two leading firms from the country shared their know-how and showcased successful open innovation cases during a recent gathering organized by a national industry association.

South Korea Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Alphaeon Corp.
  • Senior Management
  • David Moatazedi, Pres. & CEO
    Lauren Silvernail, CFO & EVP, Corp. Dev.
    J. Christopher Marmo, PhD, COO
    Rui Avelar, MD, Head, R&D & CMO
    Michael Mazen Jafar, Chief Mktg. Officer
  • Contact Info
  • Evolus Inc.
    Phone: (949) 284-4555
    17901 Von Karman Ave.
    Ste. 150
    Irvine, CA 92614
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register